The US Patent and Trademark Office (USPTO) has granted a patent to Genprex for the use of its Reqorsa gene therapy ...
Insmed has received approval from the EC for Brinsupri to treat NCFB in patients aged 12 and above with two or more ...
Merus and Halozyme have signed a worldwide non-exclusive partnership and licence agreement for subcutaneous formulation of ...
In a year where ADC deals have showed no signs of slowing, Solve has become the latest biotech to unlock an extra slice of capital.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback